-+ 0.00%
-+ 0.00%
-+ 0.00%

Tourmaline Bio Q1 EPS $(0.89) Beats $(0.91) Estimate

Benzinga·05/02/2025 11:33:31
Listen to the news
Tourmaline Bio (NASDAQ:TRML) reported quarterly losses of $(0.89) per share which beat the analyst consensus estimate of $(0.91) by 2.2 percent. This is a 61.82 percent decrease over losses of $(0.55) per share from the same period last year.